LON:SPH Sinclair Pharma (SPH) Share Price, News & Analysis → Radical change coming — do this NOW to protect yourself (From Weiss Ratings) (Ad) Free SPH Stock Alerts GBX 31.80 0.00 (0.00%) (As of 11/5/2018) Add Compare Share Share Today's Range 31.80▼ 31.8050-Day Range 31.80▼ 31.8052-Week Range 14.45▼ 32Volume373,221 shsAverage Volume3.30 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sinclair Pharma alerts: Email Address Ad Weiss RatingsMassive Crisis Looming — Protect Your Savings NowToday, Dr. Weiss is coming forward with a new warning, Only this time, it's not about the stock market, inflation, or recession … This time, it's about your financial freedom.Click here to learn how to prepare before it's too late. About Sinclair Pharma Stock (LON:SPH)Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.Read More SPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SPH Stock News HeadlinesMay 9, 2024 | msn.comSinclair jumps amid report it's exploring sale of 30% of its broadcast stationsApril 15, 2024 | yahoo.com'Respect it': Sinclair police cadets, DDN reporter get taste of pepper sprayFebruary 28, 2024 | msn.comSinclair Broadcast GAAP EPS of -$5.35 misses by $5.86, revenue of $826M misses by $14.63MFebruary 10, 2024 | health.usnews.comCheryl SinclairJanuary 23, 2024 | health.usnews.comDr. Robert SinclairDecember 17, 2023 | seekingalpha.comSinclair Continues To Face ChallengesSeptember 22, 2023 | health.usnews.comPRISCILLA A. SINCLAIRAugust 12, 2023 | health.usnews.comChristine A. SinclairAugust 1, 2023 | health.usnews.comDr. William R. SinclairJuly 21, 2023 | health.usnews.comDr. Peter SinclairMay 10, 2023 | health.usnews.comTiffany SinclairMarch 25, 2023 | health.usnews.comDr. Cassandra S. SinclairFebruary 22, 2023 | finance.yahoo.comGlobal Cosmetic Surgery Market Report 2022: Featuring Candela, Allergan, Merz Pharma, Mentor Worldwide, Lumenis, Sinclair Pharma & CuteraJanuary 12, 2023 | yahoo.comWho Is Olivia Colman’s Husband, Ed Sinclair? Here’s Everything We KnowSeptember 14, 2022 | uk.news.yahoo.comTrevor Sinclair deletes Twitter account after asking why 'black and brown' people should mourn QueenAugust 4, 2022 | finance.yahoo.comSinclair Reports Second Quarter 2022 Financial ResultsJune 29, 2022 | finance.yahoo.comSinclair (SBGI) Upgraded to Buy: What Does It Mean for the Stock?May 18, 2022 | finance.yahoo.comSinclair Pharma Partners with Vanguard Aesthetics to Launch Silhouette Soft in MalaysiaMarch 18, 2022 | lse.co.ukSinclair Pharma Share ChatSee More Headlines Receive SPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sinclair Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Major Sub-IndustryN/A Current SymbolLON:SPH CUSIPN/A CIKN/A Webwww.sinclairispharma.com Phone+44-20-74676920FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Christopher P. SpoonerCEO & Exec. DirectorMr. Alan Musgrave Olby (Age 47)CFO & Director Ms. Jayne Burrell (Age 43)Group Gen. Counsel & Company Sec. Ms. Emilie CroissantHead of Europe & Global MarketingMr. Nairn McMasterHead of Latin AmericaKey CompetitorsVectura GroupLON:VECCathay International Holdings Limited (CTI.L)LON:CTIAbzenaLON:ABZAAPR EnergyLON:APRCambian GroupLON:CMBNView All Competitors SPH Stock Analysis - Frequently Asked Questions How have SPH shares performed in 2024? Sinclair Pharma's stock was trading at GBX 31.80 at the beginning of the year. Since then, SPH shares have increased by 0.0% and is now trading at GBX 31.80. View the best growth stocks for 2024 here. What other stocks do shareholders of Sinclair Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sinclair Pharma investors own include Vectura Group (VEC), Energy Transfer (ET), Hikma Pharmaceuticals (HIK), ASOS (ASC), Cracker Barrel Old Country Store (CBRL), Jack in the Box (JACK). How do I buy shares of Sinclair Pharma? Shares of SPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SPH) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | Sponsored"Trump Loophole" Beats InflationThe demise of the "petrodollar" appears imminent. And the implications for Americans could be dire.Colonial Metals | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinclair Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinclair Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.